MSCRF (Maryland Stem Cell Research Fund)
Helps Maryland state grants for human stem cell research seven tracks covering through the MSCRF Summer.
⚠This may reflect a past cycle — verify the current call on the funder's site.
The Maryland Stem Cell Research Fund (MSCRF) was established under the Maryland Stem Cell Research Act of 2006 to promote state-funded human stem cell research and medical treatments through grants to public and private entities in Maryland. TEDCO administers the fund, which operates through a dedicated site at mscrf.org. The fund supports seven distinct sub-programmes spanning the full translation pipeline: Launch, Discovery, Validation, Commercialisation, Clinical, Post-Doctoral Fellowship, and Manufacturing Assistance. For the Summer 2026 cycle, Requests for Applications have been released and the unified submission deadline is June 23, 2026 at 5:00 PM EST. Eligibility differs by track: the Launch track targets new faculty under five years at Maryland institutions or researchers new to stem cell work; Validation is for Maryland university or research institute faculty with existing stem cell intellectual property; Commercialisation is open to start-ups and established companies developing stem cell products; Clinical requires an active Investigational New Drug (IND) application and ongoing human stem cell clinical trials in Maryland; Manufacturing Assistance targets organisations advancing Good Manufacturing Practice (GMP) stem cell production in Maryland. The Discovery track (for Maryland university faculty developing novel stem cell technologies) and the Post-Doctoral Fellowship track (for recent doctorate recipients within three years) run only in the mid-January cycle and are not open in the Summer 2026 cycle. The Clinical and Manufacturing Assistance tracks each require a 1:1 non-state match. Per-track award maximums are not published on the TEDCO programme page and must be confirmed at mscrf.org; historical figures include approximately $345,000 for Discovery, up to $300,000 for Validation, and over $1,000,000 for some Clinical awards. Applicants should review the track-specific RFAs at mscrf.org before preparing materials, as eligibility conditions differ meaningfully across sub-programmes.
State grants across seven tracks—from early discovery through clinical trials and manufacturing—for Maryland-based institutions and companies advancing human stem cell research and medical treatments.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline